Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharad Sharma

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Journal for Immunotherapy of Cancer|September 12, 2022
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regressionIlana Mandel, Dana Haves Ziv, Ilana Goldshtein, et al.
Oncoimmunology|November 23, 2020
Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockadeRita Greco, Hongjing Qu, Hui Qu, et al.
Psycho-Oncology|March 22, 2026
A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast CancerRebecca Wallace, Marliese Alexander, Daphne Day, et al.
Diabetes|May 23, 2014
Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetesAbhishek Kumar Singh, Amit Arvind Joharapurkar, Mohd Parvez Khan, et al.
Tuberculosis (Edinburgh, Scotland)|April 29, 2021
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one monthAmit K Singh, Rahul K Verma, Jatinder Kaur Mukker, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 21, 2021
Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patientsRavishankar Ramachandran, Vivek Bhosale, Himanshu Reddy, et al.
European Urology Oncology|February 22, 2026
WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on DarolutamideBarak Talmor, Carole A Harris, Christopher Gianacas, et al.
Molecular Cancer Therapeutics|September 24, 2020
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid CancerJuniper A Scribner, Jennifer G Brown, Thomas Son, et al.
Journal of Medicinal Chemistry|November 12, 2019
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical CandidateVidya Ramdas, Rashmi Talwar, Moloy Banerjee, et al.
Nature Biotechnology|September 7, 2016
Expression of an insecticidal fern protein in cotton protects against whiteflyAnoop Kumar Shukla, Santosh Kumar Upadhyay, Manisha Mishra, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|September 12, 2022
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regressionIlana Mandel, Dana Haves Ziv, Ilana Goldshtein, et al.
Oncoimmunology|November 23, 2020
Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockadeRita Greco, Hongjing Qu, Hui Qu, et al.
Psycho-Oncology|March 22, 2026
A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast CancerRebecca Wallace, Marliese Alexander, Daphne Day, et al.
Diabetes|May 23, 2014
Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetesAbhishek Kumar Singh, Amit Arvind Joharapurkar, Mohd Parvez Khan, et al.
Tuberculosis (Edinburgh, Scotland)|April 29, 2021
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one monthAmit K Singh, Rahul K Verma, Jatinder Kaur Mukker, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 21, 2021
Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patientsRavishankar Ramachandran, Vivek Bhosale, Himanshu Reddy, et al.
European Urology Oncology|February 22, 2026
WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on DarolutamideBarak Talmor, Carole A Harris, Christopher Gianacas, et al.
Molecular Cancer Therapeutics|September 24, 2020
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid CancerJuniper A Scribner, Jennifer G Brown, Thomas Son, et al.
Journal of Medicinal Chemistry|November 12, 2019
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical CandidateVidya Ramdas, Rashmi Talwar, Moloy Banerjee, et al.
Nature Biotechnology|September 7, 2016
Expression of an insecticidal fern protein in cotton protects against whiteflyAnoop Kumar Shukla, Santosh Kumar Upadhyay, Manisha Mishra, et al.
Pageof 11